Investor Relations

1.Date of institutional investor conference:2025/12/23
2.Time of institutional investor conference: 14:00 (Taiwan time)
3.Location of institutional investor conference: 18F, No. 333, Sec. 2, Dunhua S. Rd., Da'an Dist., Taipei City, Taiwan(Cathay Securities Headquarters)
4.Outline of institutional investor conference: The Company will attend Cathay Securities' investor conference to update the Company's business operations.
5.Any other matters that need to be specified: None. Related information will be disclosed on MOPS

1.Date of investor conference: 2025/10/28
2.Time of investor conference: 15:00
3.Location of investor conference: Online investor conference
4.Summary of the investor conference:
The Company has been invited to participate in Cathay Securities’ Biotech Corporate Day, during which it will brief institutional investors on the Company’s financial and operational status.
5. Other matters: None. For complete financial and business information, please refer to the “Investor Conference” section of the Market Observation Post System (MOPS).

Meeting Title: 2025 Annual Shareholders’ Meeting
Date and Time: Wednesday, June 25, 2025, at 10:00 AM (Check-in starts at 9:30 AM)
Venue: Conference Room, 2nd Floor, No. 223, Section 3, Beixin Road, Xindian District, New Taipei City (International Conference Center)

1. Date of institutional investor conference:2024/12/26
2. Time of institutional investor conference:02:30 p.m. (Taiwan time)
3. Location of institutional investor conference:
XF., No. 333, Sec. 2, Dunhua S. Rd., Da'an Dist., Taipei City, Taiwan
4. Outline of institutional investor conference:
The Company will attend Cathay Securities' investor conference to update the Company's business operations.
5. Any other matters that need to be specified: None. Related information will be disclosed on MOPS. 

Conference video link: https://youtu.be/dwV7lxU8IPM

• Download

1. Date: 2024-04-05~2024-04-10
2. Booth No.: Ground Level #1454 (Open 2024-04-08~04-10))
3. Location: San Diego Convention Center in San Diego, California, USA.
4. Content: The company’s major focus is engaging with academic and industry researchers as well as with clinicians in person, make new connections, and explore potential collaboration opportunities, which may include cooperation in clinical trials, licensing agreements, introducing late-stage or marketed novel drugs to expand the company's current product line.  Please find details via https://aacr2mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=3858885

• Video

Date：2018-01-25
The Company will launch a 2-day non-deal roadshow (NDR) in San Francisco starting from 26 Jan 2018, and the presentation file as attached.

• Download